13F-HR filed by Pivotal bioVenture Partners Investment Advisor LLC
Pivotal bioVenture Partners Investment Advisor LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-13, with 13 holding rows worth $307,788,414.
- Accession
- 0001012975-26-000759
- Filer
- CIK 1844645
- Filed
- 2026-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 13 entries on the cover page, a total value of $307,788,414 stated on the cover page (in dollars after the unit check, H1), rows summing to $307,788,414 with VALUE read as dollars as filed, 13F file number 028-20630. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerPivotal bioVenture Partners Fund I U.G.P. Ltd028-20631
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VAXCYTE INC COM | 92243G108 | Stock | 1,425,470 | $82,862,571 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 1,265,283 | $33,175,720 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,742,672 | $32,500,833 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 966,792 | $31,826,793 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 1,926,943 | $25,609,072 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 611,446 | $21,914,225 | dollars as filed | |
| OCULIS HOLDING AG | H5870P102 | CMN | 1,506,250 | $20,891,688 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 653,374 | $16,014,197 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 732,512 | $15,521,929 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 490,766 | $12,455,641 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 434,033 | $8,020,930 | dollars as filed | |
| RALLYBIO CORP | 75120L209 | COM | 300,579 | $4,809,264 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 595,518 | $2,185,551 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-26-000759 | this filing | 2026-08-13 | acceptance time not in the bulk data set |